156 related articles for article (PubMed ID: 37875045)
1. Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV.
Xu Z; Zhou H; Zhang Y; Cheng Z; Wan M; Qin W; Li P; Feng J; Shao S; Xue W; Guo H; Liu B
Biomed Pharmacother; 2023 Dec; 168():115752. PubMed ID: 37875045
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases.
Tan YQ; Chen HW; Li J
Drug Des Devel Ther; 2020; 14():3731-3746. PubMed ID: 32982178
[TBL] [Abstract][Full Text] [Related]
3. Research review on the pharmacological effects of astragaloside IV.
Li L; Hou X; Xu R; Liu C; Tu M
Fundam Clin Pharmacol; 2017 Feb; 31(1):17-36. PubMed ID: 27567103
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV: A promising natural neuroprotective agent for neurological disorders.
Yao M; Zhang L; Wang L
Biomed Pharmacother; 2023 Mar; 159():114229. PubMed ID: 36652731
[TBL] [Abstract][Full Text] [Related]
5. An updated role of astragaloside IV in heart failure.
Zang Y; Wan J; Zhang Z; Huang S; Liu X; Zhang W
Biomed Pharmacother; 2020 Jun; 126():110012. PubMed ID: 32213428
[TBL] [Abstract][Full Text] [Related]
6. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress.
Ji C; Luo Y; Zou C; Huang L; Tian R; Lu Z
BMC Pharmacol Toxicol; 2018 Sep; 19(1):53. PubMed ID: 30176914
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV, a saponin from Astragalus membranaceus var. mongholicus, induces expressions of heme recycle proteins via signaling of Nrf2/ARE in cultured macrophages.
Gong G; Yu H; Zheng Y; Qi B; He H; Yin T; Dong TT; Tsim KW
J Ethnopharmacol; 2021 Jan; 265():113389. PubMed ID: 32920134
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
Guo J; Le Y; Yuan A; Liu J; Chen H; Qiu J; Wang C; Dou X; Yuan X; Lu D
J Ethnopharmacol; 2024 Jun; 328():118080. PubMed ID: 38521426
[TBL] [Abstract][Full Text] [Related]
9. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT
Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134
[TBL] [Abstract][Full Text] [Related]
10. Research progress of astragaloside IV in the treatment of atopic diseases.
Yu S; Peng W; Qiu F; Zhang G
Biomed Pharmacother; 2022 Dec; 156():113989. PubMed ID: 36411656
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological effects of Astragaloside IV: a literature review.
Ren S; Zhang H; Mu Y; Sun M; Liu P
J Tradit Chin Med; 2013 Jun; 33(3):413-6. PubMed ID: 24024343
[TBL] [Abstract][Full Text] [Related]
12. The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease.
Gao Y; Su X; Xue T; Zhang N
Biomed Pharmacother; 2023 Jul; 163():114598. PubMed ID: 37150034
[TBL] [Abstract][Full Text] [Related]
13. Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis.
Ren C; Zhao X; Liu K; Wang L; Chen Q; Jiang H; Gao X; Lv X; Zhi X; Wu X; Li Y
J Ethnopharmacol; 2023 Apr; 305():116128. PubMed ID: 36623754
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
Zhang J; Wu C; Gao L; Du G; Qin X
Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV relieves gestational diabetes mellitus in genetic mice through reducing hepatic gluconeogenesis.
Zhang R; Xing B; Zhao J; Zhang X; Zhou L; Yang S; Wang Y; Yang F
Can J Physiol Pharmacol; 2020 Jul; 98(7):466-472. PubMed ID: 32160476
[TBL] [Abstract][Full Text] [Related]
16. Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases.
Tan J; Yi J; Cao X; Wang F; Xie S; Dai A
Drug Des Devel Ther; 2023; 17():1963-1978. PubMed ID: 37426627
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV protects against polymicrobial sepsis through inhibiting inflammatory response and apoptosis of lymphocytes.
Liu R; Jiang H; Tian Y; Zhao W; Wu X
J Surg Res; 2016 Jan; 200(1):315-23. PubMed ID: 26375505
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.
Lin J; Fang L; Li H; Li Z; Lyu L; Wang H; Xiao J
Eur J Pharmacol; 2019 Sep; 859():172490. PubMed ID: 31229536
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.
Wang ZF; Ma DG; Zhu Z; Mu YP; Yang YY; Feng L; Yang H; Liang JQ; Liu YY; Liu L; Lu HW
World J Gastroenterol; 2017 Dec; 23(48):8512-8525. PubMed ID: 29358859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
